Publications by authors named "Johann Fischaleck"
Article Synopsis
- The study aimed to investigate the prevalence of multiple sclerosis (MS) and related healthcare practices in Bavaria, Germany, using insurance claims data.
- The administrative prevalence of MS in Bavaria rose from 0.123% to 0.175% between 2005 and 2009, suggesting there are approximately 102,000-143,000 MS patients in Germany.
- The research found that while the percentage of patients receiving disease-modifying drugs increased from 45.5% to 50.5%, neurologists predominantly treated these patients in outpatient settings.
Aims: There are concerns that biosimilar erythropoiesis-stimulating agents (ESAs) are less effective than the originator ESAs. The objective of our study was to investigate differences between originator and biosimilar ESA utilisation based on defined daily doses (DDD), doses upon switching, differences between short- and long-acting ESAs and prescribed daily doses (PDD) of either ESA in ambulatory patients with renal anaemia undergoing chronic maintenance haemodialysis [chronic kidney disease (CKD) stage 5].
Methods: Patients with CKD stage 5 and specific pharmacotherapy with ESAs for at least six 3-month periods (accounting quarters) were selected from a population-based database of accounting information of Bavarian physicians and pharmacy claims data (January 2008 to December 2010).